Skip to main content
. 2012 Jun 3;1(1):82–88. doi: 10.1002/cam4.2

Table 2.

HPV and p16 prevalence in different sub-sites1

HPV+2 HPV−2


Sub-site All patients (n = 69) p16+2 (n = 8) p16−2 (n = 4) p16+2 (n = 9) p16−2 (n = 48)
C051–C058 26 2 (8) 3 (12) 5 (19) 16 (62)
C101–C109 43 6 (14) 1 (2) 4 (9) 32 (74)

Values are expressed as n (%).

1

P = 0.212 Fischer's exact test.

2

Presence of HPV-DNA and expression of p16 in tumors analyzed using PCR and IHC, respectively.